Forbes February 3, 2023
Joshua Cohen

Amazon is adding RxPass to its pharmacy footprint. Purportedly, it’s competing with Mark Cuban’s Cost Plus Drug Company (MCCPDC). But, limitations suggest it isn’t yet a real competitor.

By paying a monthly flat fee of $5 an Amazon Prime members can obtain as many generic drugs as they need, among an initial set of 50 medications indicated for conditions, such as high blood pressure, anxiety, and male pattern baldness. Amazon’s new initiative will operate within its existing pharmacy infrastructure and distribution channels.

Paying a low, flat cash rate for generics isn’t unprecedented. Walmart, among others, has such a program.

And, for two years Mark Cuban’s Cost Plus Drug Company (MCCPDC) has been making waves in the cash business for generic...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Pharma, Pharma / Biotech
Contributed Content: 2 Alternatives to Ineffective Prescription Drug Rebates
Pharma Pulse 7/25/24: Driving CAR-Ts for Treatment in Cancer and Immunology, CrowdStrike Explains What Went Wrong in Global Outage & more
Fueled With $100M, Autobahn Therapeutics Gears Up for Depression Drug Clinical Trials
Q&A: The Superman Pharmacist Shares His Vision For Community Pharmacy
STAT+: A preview of Neurocrine’s muscarinic drug readout

Share This Article